Metraipolis › archive › dc_afcbae151c05
Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a… — Europe PMC PMID:42043935
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42043935
- DOI
- 10.2196/87156
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T02:41:01.583Z
- SHA-256 of the archived text
6a005a8eb16fe9186ebbb9e39687e1e520f4c98bb3be91434da9de8d3a1aa516- Stable URL of this page
https://metraipolis.com/documento/dc_afcbae151c05
How to cite
Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a… — Europe PMC PMID:42043935 — Europe PMC (en), https://europepmc.org/article/MED/42043935 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_afcbae151c05 (Metraipolis archive dc_afcbae151c05, sha256 6a005a8eb16fe9186ebbb9e39687e1e520f4c98bb3be91434da9de8d3a1aa516)
BibTeX
@misc{dcafcbae151c05,
title = {Tripterygium Glycoside Tablets Combined With Conventional Synthetic Disease-Modifying Antirheumatic Drugs for Treating Rheumatoid Arthritis: Protocol for a… — Europe PMC PMID:42043935},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42043935},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_afcbae151c05; sha256 6a005a8eb16fe9186ebbb9e39687e1e520f4c98bb3be91434da9de8d3a1aa516},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42043935. Agents can read the archived copy with the MCP tool read_document.